Customer Support: 131 242

Your region & currency

Australia English(AU)

Pricing in AUD $

Local sites

  • Shopping Cart
    There are no items in your cart

We noticed you are browsing from United States. Switch to our United States site for local pricing in USD.

Dismiss alert
Wiring Rules bundle. AS/NZS 3000 + 3008.1.1 with 10% off already included. Shop Now

BS EN ISO 10993-3:2026

Current

Current

The latest, up-to-date edition.

Biological evaluation of medical devices Evaluation of genotoxicity, carcinogenicity, reproductive toxicity and developmental toxicity

Available format(s)

Hardcopy , PDF

Language(s)

English

Published date

08-10-2026

$737.91
Including GST where applicable
Summarise this standard

Committee
CH/194
DocumentType
Standard
Pages
56
PublisherName
British Standards Institution
Status
Current
Supersedes

This document specifies strategies for risk estimation and evaluation of biological harms with respect to: genotoxicity; carcinogenicity; reproductive toxicity; and developmental toxicity. This document is applicable when the need to evaluate a medical device for potential genotoxicity, carcinogenicity, reproductive toxicity and developmental toxicity has been established. This document is not applicable to active pharmaceutical ingredients of device-drug combination products or biological components of device-biologic combination products which are covered by regulations. NOTE Guidance on selecting relevant biological effects for medical devices is covered in ISO10993-1.

Standards Relationship
ISO 10993-3:2026 Identical
EN ISO 10993-3:2026 Equivalent
I.S. EN ISO 10993-3:2026 Equivalent
DIN EN ISO 10993-3:2026-11 Equivalent

$737.91
Including GST where applicable